Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Aurora Innovation Inc (AUR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Avidity Biosciences (RNA)
-
Cantor Fitzgerald Starts Tenable (TENB) at Overweight
-
Cantor Fitzgerald Starts Okta, Inc (OKTA) at Overweight
-
Civil-exposed names will likely see volatility compared to defense, says Cantor
-
Cantor Fitzgerald Reiterates Overweight Rating on 3D Systems (DDD)
-
Cantor Fitzgerald Reiterates Overweight Rating on Compass Pathways (CMPS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Mereo BipPharma Group (MREO)
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $123 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Robinhood Markets (HOOD)
-
Cantor Fitzgerald Reiterates Overweight Rating on Zai Lab (ZLAB)
-
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
-
Terrestrial Energy to Become First Publicly Traded Molten Salt Nuclear Reactor Developer Through Combination with HCM II Acquisition Corp. (HOND)
-
Terrestrial Energy to Become First Publicly Traded Molten Salt Nuclear Reactor Developer Through Combination with HCM II Acquisition Corp.
-
Cantor Fitzgerald Reiterates Overweight Rating on Kalvista Pharmaceuticals Inc (KALV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Sanara MedTech (SMTI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD)
-
Cantor Fitzgerald Reiterates Overweight Rating on X4 Pharmaceuticals (XFOR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)
-
Investcorp Credit Management BDC, Inc. Announces Financial Results for the Fiscal Period Ended December 31, 2024, and Quarterly Distribution
-
Cantor Fitzgerald Reiterates Overweight Rating on Alphabet (GOOGL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Meta Platforms Inc. (META)
-
Intuitive Machines Inc. (LUNR) PT Lowered to $13 at Cantor Fitzgerald
-
Artiva Biotherapeutics (ARTV) PT Lowered to $20 at Cantor Fitzgerald
-
Intuitive Machines shares surge on growing space contracts, stronger cash position
-
Anticipation Builds for the Centri Capital Conference at Nasdaq on April 22
-
Strategy (MSTR) acquired approximately 6,911 more bitcoins
-
Cantor Fitzgerald Reiterates Overweight Rating on Joby Aviation Inc (JOBY)
-
Cantor Fitzgerald Reiterates Overweight Rating on EVgo, Inc. (EVGO)
-
Cantor Fitzgerald Reiterates Overweight Rating on VinFast Auto Ltd. (VFS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Riot Platforms (RIOT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Intuitive Machines Inc. (LUNR)
-
Cantor Fitzgerald Reiterates Overweight Rating on PureCycle Technolgies (PCT)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Aurora Innovation Inc (AUR)
-
Form 424B3 Cantor Fitzgerald Income
-
Tether is in talks with 'Big Four' firm about reserve audit, CEO says
-
Cantor Fitzgerald Starts Summit Therapeutics plc (SMMT) at Overweight
-
Strategy (MSTR) Prices Perpetual Strife Preferred Stock Offering
-
Strategy Prices Perpetual Strife Preferred Stock Offering
-
Cantor Fitzgerald Reiterates Overweight Rating on MannKind (MNKD)
-
Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Planet Labs (PL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Amprius Technologies (AMPX)
